Rukobia Tablet, Film Coated, Extended Release
Product Images NDC 49702-250

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rukobia (NDC 49702-250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fostemsavir Tromethamine Chemical Structure (Rukobia Spl Graphic 01)

FDA Label Image

Rukobia 600 mg 60 Count Carton (Rukobia Spl Graphic 02)

Rukobia 600 mg 60 Count Carton (Rukobia Spl Graphic 02)
Rukobia (fostemsavir) is a prescription drug that comes in the form of extended-release tablets. Each tablet contains 600 mg of fostemsavir, which is equivalent to 725 mg fostemsavir tromethamine. Pharmacists are advised not to cover the ALERT box with the pharmacy label, and patients are instructed to find out about medicines that should not be taken with Rukobia. The NDC number for this drug is 49702-250-18.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.